Suppr超能文献

用于蛋白质递送系统的海藻酸盐包封脂质体(LIA)的制备与表征

Preparation and characterization of liposomes-in-alginate (LIA) for protein delivery system.

作者信息

Dai Chuanyun, Wang Bochu, Zhao Hongwei, Li Biao, Wang Jian

机构信息

Key Laboratory of Biomechanics & Tissue Engineering Under the Sate Ministry of Education, College of Bioengineering, Chongqing University, Chongqing 400044, PR China.

出版信息

Colloids Surf B Biointerfaces. 2006 Feb 1;47(2):205-10. doi: 10.1016/j.colsurfb.2005.07.013. Epub 2006 Jan 30.

Abstract

This paper describes the preparation and characterization of a novel drug delivery system for protein, liposomes-in-alginate (LIA) of biodegradable polymers, which is conceived from a combination of the polymer and the lipid-based delivery systems. LIA were prepared by first entrapping bovine serum albumin (BSA), a model protein within multivesicular liposomes (MVLs) by double emulsification process, which are then encapsulated within alginate hydrogel microcapsule, with untrapped BSA which are added during preparation of MVLs. Factors impacting encapsulation efficiency of MVLs are investigated and release of protein from the microcapsules in vitro is studied. At the same time, characterization of MVLs, microcapsules encapsulated protein formulation and integrality analyse of BSA in microcapsules are also studied, with the aim of improving the entrapment efficiency and prolonging release time. It is found that encapsulation efficiency and size of MVLs are affected by the composition and fabrication parameters of LIA. The data also show LIA have high encapsulation efficiency (up to 95%), little chemical change in drug caused by the formulation process, narrow particle size distribution and spherical particle morphology. Drug release assays conducted in vitro indicates that these formulations provide sustained release of encapsulated drug over a period, about 2 weeks.

摘要

本文描述了一种新型蛋白质药物递送系统的制备与表征,即生物可降解聚合物海藻酸盐包载脂质体(LIA),它是由聚合物和基于脂质的递送系统组合而成。LIA的制备方法是,首先通过复乳化法将模型蛋白牛血清白蛋白(BSA)包裹在多囊泡脂质体(MVL)中,然后将其包封在海藻酸盐水凝胶微胶囊内,在制备MVL的过程中加入未包裹的BSA。研究了影响MVL包封效率的因素,并研究了微胶囊中蛋白质的体外释放情况。同时,还研究了MVL的表征、包封蛋白质制剂的微胶囊以及微胶囊中BSA的完整性分析,目的是提高包封效率和延长释放时间。研究发现,MVL的包封效率和尺寸受LIA的组成和制备参数影响。数据还表明,LIA具有高包封效率(高达95%),制剂过程对药物的化学变化影响小,粒径分布窄且颗粒形态呈球形。体外药物释放试验表明,这些制剂能在约2周的时间内持续释放包封的药物。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验